1. The problem of nonresponding estrogen receptor-positive patients with advanced breast cancer;Maas;Cancer,1980
2. The pharmacology and clinical uses of tamoxifen;Furr;Pharmacol. Ther.,1984
3. Uterine bioassay of tamoxifen, trioxifene and a new estrogen antagonist (LY 117018) in rats and mice;Black;Life Sci,1980
4. MCF7/LCC2: a 4-hydroxytamoxifen resistant human breast cancer variant that retains sensitivity to the steroidal antiestrogen ICI 182,780;Brünner;Cancer Res,1993
5. The future of new pure antiestrogens in clinical breast cancer. Breast Cancer Res;Wakeling;Treat.,1993